You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ANRO Exercise Disclosure
Smith Nicholas Conrad · SEC Form 4 · Filed Oct 1, 2026
Exercise
Calculated transaction value
$0
Smith Nicholas Conrad President And CFO
ANRO
Transaction date
Sep 30, 2026
Public filing date
Oct 1, 2026
Filing lag
Filed 1 day later
ANRO daily price context
Close on/before transaction
$25.53
Sep 30, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 24,056 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0002009130-26-000004
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$3.88M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Alto Neuroscience, Inc. ANRO | Exercise | Sep 30, 2026 | $56.53K |
| Alto Neuroscience, Inc. ANRO | Sale | Sep 30, 2026 | $597.29K |
| Alto Neuroscience, Inc. ANRO | Sale | Sep 30, 2026 | $23.81K |
| Alto Neuroscience, Inc. ANRO Current | Exercise | Sep 30, 2026 | $0 |
| Alto Neuroscience, Inc. ANRO | Exercise | Sep 29, 2026 | $0 |
| Alto Neuroscience, Inc. ANRO | Exercise | Sep 29, 2026 | $132.67K |
| Alto Neuroscience, Inc. ANRO | Exercise | Sep 29, 2026 | $127.78K |
| Alto Neuroscience, Inc. ANRO | Exercise | Sep 29, 2026 | $0 |
| Alto Neuroscience, Inc. ANRO | Sale | Sep 29, 2026 | $2.95M |